Treatment of motor and behavioural symptoms in three Lesch-Nyhan patients with intrathecal baclofen.
Orphanet J Rare Dis
; 9: 208, 2014 Dec 12.
Article
em En
| MEDLINE
| ID: mdl-25497359
ABSTRACT
Current therapies for the Lesch-Nyhan Syndrome (OMIM 300322) are off-label and experimental, often leading to inconsistent outcomes. We here report the effects of an intrathecal baclofen therapy, carried out at the Scientific Institute Eugenio Medea (Lecco, Italy), on three patients who no longer received benefit from previous therapies. This treatment, as expected, ameliorated the motor symptoms and, unexpectedly, it also improved behavioural components. This result may involve a functional interaction between baclofen and dopamine, complemented by an anxiolytic effect. Our observations provide the rationale for the use of intrathecal baclofen administration in the therapy of the Lesch-Nyhan Syndrome.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Baclofeno
/
Comportamento Autodestrutivo
/
Transtornos das Habilidades Motoras
/
Síndrome de Lesch-Nyhan
Idioma:
En
Ano de publicação:
2014
Tipo de documento:
Article